600713 Nanjing Pharmaceutical
- 5.12
- -0.01-0.19%
About Nanjing Pharmaceutical Company
The company was founded in 1951 and listed on the Shanghai Stock Exchange in 1996. It is an early listed company in the Chinese pharmaceutical distribution industry, and has now developed into a cross-regional, networked group enterprise. At the end of 2014, the company introduced overseas strategic investors to actively explore mixed ownership reforms. The state-owned controlling shareholder is Nanjing Xingong Investment Group Co., Ltd. (holding 44.13%), a Chinese Fortune 500 company; the foreign shareholder is AllianceHealthCareAsiaPacificLimited (holding 11.03%), a subsidiary of the world's top 500 WalgreensBootSalesian (Wobo Union). The company's main business includes pharmaceutical wholesale, pharmaceutical retail, pharmaceutical “Internet +” and pharmaceutical third-party logistics services. Corporate honors: It won the first prize of the National Management Innovation Achievement Award in 2011; projects such as “Internet+ Pharmacy Service” and “New Supply Chain Service Model Based on Traditional Chinese Medicine Pharmaceutical Services” were awarded by industry associations; the “Doctor-Patient Smart Traditional Chinese Medicine Pharmacy Service” project was successfully awarded the “2018 Smart Jiangsu Key Project”. The company won the “12th Five-Year Plan” Best Management Innovation Award in China's pharmaceutical distribution industry; won the honorary title of “2017-2018 National Drug Distribution Innovation Demonstration Enterprise”.
Company Profile
Company Executives
- Name
- Position
- Salary
- jianjun zhou
- Chairman, Directors, Chairman of the Strategic Decision and Investment and Financing Management Committee
- 2.19M
- Marco Kerschen
- Directors, Member of the Remuneration and Performance Appraisal Committee, Member of the Nomination and Human Resources Planning Committee
- --
- jing zhang
- Directors, President
- 2.10M
- jiannan xu
- Directors, Member of the Nomination and Human Resources Planning Committee
- 1.79M
- zhihong lu
- Directors, Member of the Audit and Risk Control Committee, Member of the Remuneration and Performance Appraisal Committee
- --
- xunjie luo
- Directors, VP, Member of the Strategic Decision and Investment and Financing Management Committee, Member of the Audit and Risk Control Committee
- 1.41M
- wei lv
- Independent Directors, Member of the Nomination and Human Resources Planning Committee, Member of the Strategic Decision and Investment and Financing Management Committee, Chairman of the Audit and Risk Control Committee, Member of the Remuneration and Performance Appraisal Committee
- --
- chunhui wang
- Independent Directors, Chairman of the Nomination and Human Resources Planning Committee, Member of the Strategic Decision and Investment and Financing Management Committee, Member of the Audit and Risk Control Committee, Member of the Remuneration and Performance Appraisal Committee
- 120.00K
- yindi lu
- Independent Directors, Chairman of the Remuneration and Performance Appraisal Committee, Member of the Audit and Risk Control Committee, Member of the Strategic Decision and Investment and Financing Management Committee, Member of the Nomination and Human Resources Planning Committee
- 120.00K
- wenjun li
- Board Secretary, VP
- 1.51M
- guan wang
- Securities Affairs Representative
- --
- yuanyuan xu
- Chairman of the Supervisory Board, Auditors
- --
- qing yang
- auditors, Chief Auditor (Head of Audit)
- 994.00K
- chuang feng
- VP
- 1.51M
- jianzhong tang
- VP
- 1.53M
- yuping peng
- VP
- 1.08M
- hong xiao
- VP
- --
- jian sun
- Chief Accountant (Finance Officer)
- 1.25M
- qiushuang wang
- Chief Engineer
- 1.71M
- xia yao
- Employee Supervisors
- 1.36M
Analysis
Price Target
No Data
No Data